NCT07506005 Anastomotic Bleeding in Colorectal Anastomosis Relating to the Placement of the Stapler Spike to the Staple Line
| NCT ID | NCT07506005 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kepler University Hospital |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 102 participants |
| Start Date | 2024-12-18 |
| Primary Completion | 2028-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 102 participants in total. It began in 2024-12-18 with a primary completion date of 2028-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Each colorectal anastomosis is routinely evaluated intraoperatively by sigmoidoscopy and, in the presence of signs of bleeding, also postoperatively (persistent rectal bleeding within 24 hours after surgery).
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Colorectal surgery with primary colorectal anastomosis using the double-stapling technique, including side-to-end or end-to-end anastomosis * Documented anastomotic orientation (mesenteric vs. antimesenteric) Exclusion Criteria: * TME
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07506005 clinical trial?
This trial is open to participants of all sexes, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07506005 currently recruiting?
Yes, NCT07506005 is actively recruiting participants. Contact the research team at sandra.raab@kepleruniklinikum.at for enrollment information.
Where is the NCT07506005 trial being conducted?
This trial is being conducted at Linz, Austria.
Who is sponsoring the NCT07506005 clinical trial?
NCT07506005 is sponsored by Kepler University Hospital. The trial plans to enroll 102 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.